https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung?utm_medium=email&utm_source=govdelivery [5]Libtayo® (cemiplim...
A comprehensive list of the US FDA’s Center for Drug Evaluation & Research (CDER)'s new drug therapy approvals for 2022. CDER approved 37 new drugs in 2022, down from50 in 2021, either as new molecular entities (NMEs) under New Drug Applications (NDAs), or as new therapeutic biologics...
Last year, the US FDA approved 50 new drugs. For the first quarter of 2022, it has so far approved seven andis expecting to make decisions on five more by the end of this month. (By WuXi AppTec content team.Click the ima...
特别是,多种获批新药针对罕见病(Rare Disease)的治疗,包括转移性或不可切除的葡萄膜黑色素瘤、肌萎缩性侧索硬化症(ALS)、广泛性脓疱性银屑病等,将有助于解决未满足的临床需求,改善患者的生活质量。让我们期待2023年更多的创新药物获批! 点击查看: [1]. FDA website.FDA Approved Many New Drugs in 2022 That...
Last year, the US FDA approved 50 new drugs. For the first quarter of 2022, it has so far approved seven andis expecting to make decisions on five more by the end of this month. (By WuXi AppTec content team.Click the image to view at full size) ...
March 2022 for AMX0035 in the US for people living with ALS that meet program eligibility criteria but ineligible for the trial. If approved, AMX0035 would offer a new treatment option which can help delay medical interventions, such as mechanical ventilation, for ALS patients. ...
2.8 Resources for Information on Approved Drugs（批准信息查询）点击“图3”中左侧“Resources for Information on Approved Drugs”，下拉至最底部，界面如下。▲ 图-29 1） 点击“图29”中“New Drugs at FDA”可获得2015年～2022年FDA批准的新药。▲ 图-30 ▲图-31 2） 点击“图29”中“First Generic ...
Vidaza (azacitidine)– New indication approved for juvenile myelomonocytic leukemia. SUGGESTED for you Xalkori (crizotinib)– New indication for adults and children aged 1 year and older with unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive myofibroblastic tumors...
SUGGESTED for you Adlarity (donepezil transdermal)– New transdermal patch indicated for treatment of mild, moderate, and severe Alzheimer dementia; originally approved as tablet and oral disintegrating tablet. Hyftor (sirolimus topical)– New dosage form indicated for treatment of facial angiofibroma ...
FDA approves tirzepatide: A potent new drug for type 2 diabetes 图片上传失败 重试 The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is called tirzepatide. A person has it as a once-weekly injection under the skin. ...